Loading...
•
Sep 30, 2021
BD Q4 2021 Earnings Report
BD's Q4 2021 earnings report was announced, revealing a mix of growth and challenges.
Key Takeaways
BD reported a 7.3% increase in revenue to $5.1 billion for the fourth fiscal quarter. GAAP EPS increased 133.3% to $0.84, while adjusted EPS decreased 7.2% to $2.59. The company issued fiscal year 2022 revenue guidance of $19.3 to $19.5 billion and adjusted diluted EPS guidance of $12.30 to $12.50.
Fourth fiscal quarter revenues increased by 7.3% to $5.1 billion.
GAAP diluted earnings per share increased 133.3% to $0.84.
Adjusted diluted EPS decreased 7.2% to $2.59.
Fiscal year 2022 revenue guidance is $19.3 to $19.5 billion.
Revenue by Geographic Location
Forward Guidance
BD expects fiscal year 2022 revenues to be in the range of $19.3 to $19.5 billion and adjusted diluted EPS to be $12.30 to $12.50.
Positive Outlook
- Base business currency-neutral revenue growth of 5% to 6%
- Continued momentum across our businesses driven by our BD 2025 growth strategy
- Continued recovery from the COVID-19 pandemic
- Approximately $200 million in COVID-19-only diagnostic testing revenues
- Improved margin profile.
Challenges Ahead
- Foreign exchange would represent a headwind of approximately 50 basis points to total company revenue growth.
- Potential charges or gains that may be recorded during the fiscal year
- Non-cash amortization of intangible assets
- Acquisition-related charges
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...